Ann: PAT-DX1 Active in Pre-clinical Cancer Models, page-138

I personally doubt we will see this over 2 cents again simply because these are PRE clinical trial results and we saw a 350 percent rise on Thursday.
It doesn't worry me either way, as I'm holding large free carried , however I am referring to your comments regarding FDA approvals.
These approvals will be given if and when successful clinical trials are complete which take years and big money to complete.
Any thing else regarding buy out deals is just crazy speculation at this early stage.
That is where I am coming from.
Let's not count our chickens before they hatch.
PAB has just come off a .004 base.we are now,at 1.8/1.9 lol.that's near 500% rise. I prefered buying at .004/.006.